These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17919697)

  • 21. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
    Zinkgraf K; Quinn AO; Ketterhagen D; Kreuziger B; Stevenson K
    Urol Nurs; 2009; 29(1):30-4. PubMed ID: 19331273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcutaneous electrical nerve stimulation as add-on therapy in children receiving anticholinergics and/or mirabegron for refractory daytime urinary incontinence: A retrospective cohort study.
    Pedersen N; Breinbjerg A; Thorsteinsson K; Hagstrøm S; Rittig S; Kamperis K
    Neurourol Urodyn; 2022 Jan; 41(1):275-280. PubMed ID: 34618378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
    Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML
    J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study.
    Coronas Soucheiron M; Casal Beloy I; Villalón Ferrero FN; Martín Solé O; Capdevila Vilaró B; González Temprano N; Larreina De la Fuente L; García González M; Carbonell Pradas M; Pérez Bertólez S; Tarrado Castellarnau X; García Aparicio L; Somoza Argibay I
    Cir Pediatr; 2023 Oct; 36(4):180-185. PubMed ID: 37818900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
    Chancellor MB; Zinner N; Whitmore K; Kobashi K; Snyder JA; Siami P; Karram M; Laramée C; Capo' JP; Seifeldin R; Forero-Schwanhaeuser S; Nandy I
    Clin Ther; 2008 Oct; 30(10):1766-81. PubMed ID: 19014833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of outcome in children and adolescents with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation.
    Hoffmann A; Sampaio C; Nascimento AA; Veiga ML; Barroso U
    J Pediatr Urol; 2018 Feb; 14(1):54.e1-54.e6. PubMed ID: 28974365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasacral transcutaneous electrical stimulation for overactive bladder in children: An assessment per session.
    Veiga ML; Queiroz AP; Carvalho MC; Braga AA; Sousa AS; Barroso U
    J Pediatr Urol; 2016 Oct; 12(5):293.e1-293.e5. PubMed ID: 27142765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.
    Ridout AE; Yoong W
    J Obstet Gynaecol; 2010 Feb; 30(2):111-4. PubMed ID: 20143965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous parasacral electrical stimulation vs oxybutynin for the treatment of overactive bladder in children: a randomized clinical trial.
    Quintiliano F; Veiga ML; Moraes M; Cunha C; de Oliveira LF; Lordelo P; Bastos Netto JM; Barroso Júnior U
    J Urol; 2015 May; 193(5 Suppl):1749-53. PubMed ID: 25813563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
    Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
    Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpharmacological treatment of lower urinary tract dysfunction using biofeedback and transcutaneous electrical stimulation: a pilot study.
    Barroso U; Lordêlo P; Lopes AA; Andrade J; Macedo A; Ortiz V
    BJU Int; 2006 Jul; 98(1):166-71. PubMed ID: 16831163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
    Nitti VW; Dmochowski R; Sand PK; Forst HT; Haag-Molkenteller C; Massow U; Wang J; Brodsky M; Bavendam T
    J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parasacral transcutaneous electrical nerve stimulation for overactive bladder in constipated children: The role of constipation.
    Veiga ML; Costa EV; Portella I; Nacif A; Martinelli Braga AA; Barroso U
    J Pediatr Urol; 2016 Dec; 12(6):396.e1-396.e6. PubMed ID: 27426685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability.
    Hasan ST; Robson WA; Pridie AK; Neal DE
    J Urol; 1996 Jun; 155(6):2005-11. PubMed ID: 8618309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
    Van Arendonk KJ; Knudson MJ; Austin JC; Cooper CS
    Urology; 2006 Oct; 68(4):862-5. PubMed ID: 17070368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder: A Randomized Controlled Trial.
    Liu Y; Xu G; Geng J
    Am J Phys Med Rehabil; 2022 Jan; 101(1):2-10. PubMed ID: 34225282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.